SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-038023
Filing Date
2024-03-28
Accepted
2024-03-28 16:05:43
Documents
73
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K elym-20231231.htm   iXBRL 10-K 2225753
2 EX-10.13 elym-ex10_13.htm EX-10.13 122319
3 EX-10.14 elym-ex10_14.htm EX-10.14 163824
4 EX-23.1 elym-ex23_1.htm EX-23.1 3415
5 EX-31.1 elym-ex31_1.htm EX-31.1 14144
6 EX-32.1 elym-ex32_1.htm EX-32.1 10330
7 EX-97.1 elym-ex97_1.htm EX-97.1 36831
8 GRAPHIC img157705552_0.jpg GRAPHIC 60248
  Complete submission text file 0000950170-24-038023.txt   9443339

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT elym-20231231.xsd EX-101.SCH 1354993
77 EXTRACTED XBRL INSTANCE DOCUMENT elym-20231231_htm.xml XML 1550979
Mailing Address 2801 CENTERVILLE ROAD 1ST FLOOR PMB #117 WILMINGTON DE 19808
Business Address 2801 CENTERVILLE ROAD 1ST FLOOR PMB #117 WILMINGTON DE 19808 877-354-3689
Eliem Therapeutics, Inc. (Filer) CIK: 0001768446 (see all company filings)

IRS No.: 832273741 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-40708 | Film No.: 24798801
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)